MORGAN STANLEY - CANDEL THERAPEUTICS INC ownership

CANDEL THERAPEUTICS INC's ticker is and the CUSIP is 137404109. A total of 24 filers reported holding CANDEL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of CANDEL THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$165
-99.0%
92
-98.3%
0.00%
Q3 2022$17,000
+13.3%
5,280
+14.3%
0.00%
Q2 2022$15,000
-37.5%
4,621
-0.6%
0.00%
Q1 2022$24,000
-33.3%
4,651
-1.5%
0.00%
Q4 2021$36,0004,7220.00%
Other shareholders
CANDEL THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Northpond Ventures, LLC 1,935,215$1,780,3985.13%
Sands Capital Ventures, LLC 811,737$746,7980.22%
Empirical Asset Management, LLC 10,000$9,2000.01%
Baystate Wealth Management LLC 97,310$89,5250.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,595$123,3130.00%
FRANKLIN RESOURCES INC 1,125,000$1,046,2500.00%
OneDigital Investment Advisors LLC 25,428$23,3940.00%
WELLS FARGO & COMPANY/MN 108$990.00%
NORTHERN TRUST CORP 19,617$18,0480.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CANDEL THERAPEUTICS INC shareholders